BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19383885)

  • 1. Physical activity as a determinant of fecal bile acid levels.
    Wertheim BC; Martínez ME; Ashbeck EL; Roe DJ; Jacobs ET; Alberts DS; Thompson PA
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1591-8. PubMed ID: 19383885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations.
    Jacobs ET; Haussler MR; Alberts DS; Kohler LN; Lance P; Martínez ME; Roe DJ; Jurutka PW
    Cancer Prev Res (Phila); 2016 Jul; 9(7):589-97. PubMed ID: 27138789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
    van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
    Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, double-blinded, placebo-controlled study of effect of wheat bran fiber and calcium on fecal bile acids in patients with resected adenomatous colon polyps.
    Alberts DS; Ritenbaugh C; Story JA; Aickin M; Rees-McGee S; Buller MK; Atwood J; Phelps J; Ramanujam PS; Bellapravalu S; Patel J; Bextinger L; Clark L
    J Natl Cancer Inst; 1996 Jan; 88(2):81-92. PubMed ID: 8537982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial.
    Alberts DS; Einspahr JG; Earnest DL; Krutzsch MF; Lin P; Hess LM; Heddens DK; Roe DJ; Martínez ME; Salen G; Batta AK
    Cancer Epidemiol Biomarkers Prev; 2003 Mar; 12(3):197-200. PubMed ID: 12646507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas.
    de Kok TM; van Faassen A; Glinghammar B; Pachen DM; Eng M; Rafter JJ; Baeten CG; Engels LG; Kleinjans JC
    Dig Dis Sci; 1999 Nov; 44(11):2218-25. PubMed ID: 10573365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis.
    Wertheim BC; Smith JW; Fang C; Alberts DS; Lance P; Thompson PA
    Cancer Prev Res (Phila); 2012 Feb; 5(2):197-204. PubMed ID: 22058145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal bile acids in patients with adenomatous polyps of the colon. Case-control study.
    Breuer NF; Jaekel S; Dommes P; Goebell H
    Digestion; 1986; 34(2):87-92. PubMed ID: 3732642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal bile acid excretion in patients with colon cancer, colon polyp and peptic ulcer.
    Makino T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):297-305. PubMed ID: 6537041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
    Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
    Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile acid metabolism in rats fed two levels of corn oil and brans of oat, rye and barley and sugar beet fiber.
    Gallaher DD; Locket PL; Gallaher CM
    J Nutr; 1992 Mar; 122(3):473-81. PubMed ID: 1311754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
    Thompson PA; Wertheim BC; Roe DJ; Ashbeck EL; Jacobs ET; Lance P; Martínez ME; Alberts DS
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1023-30. PubMed ID: 19952360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas.
    Boutron-Ruault MC; Marteau P; Lavergne-Slove A; Myara A; Gerhardt MF; Franchisseur C; Bornet F;
    Nutr Cancer; 2005; 53(2):160-8. PubMed ID: 16573377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of resistant starch on potential biomarkers for colonic cancer risk in patients with colonic adenomas: a controlled trial.
    Grubben MJ; van den Braak CC; Essenberg M; Olthof M; Tangerman A; Katan MB; Nagengast FM
    Dig Dis Sci; 2001 Apr; 46(4):750-6. PubMed ID: 11330408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial.
    Little J; Owen RW; Fernandez F; Hawtin PG; Hill MJ; Logan RF; Thompson MH; Hardcastle JD
    Dis Colon Rectum; 2002 Sep; 45(9):1233-41. PubMed ID: 12352242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic epidemiology of colon cancer: effect of dietary fiber on fecal mutagens and bile acids in healthy subjects.
    Reddy BS; Sharma C; Simi B; Engle A; Laakso K; Puska P; Korpela R
    Cancer Res; 1987 Jan; 47(2):644-8. PubMed ID: 3024823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies.
    Bernstein C; Bernstein H; Garewal H; Dinning P; Jabi R; Sampliner RE; McCuskey MK; Panda M; Roe DJ; L'Heureux L; Payne C
    Cancer Res; 1999 May; 59(10):2353-7. PubMed ID: 10344743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
    Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
    J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age, intestinal transit time, and dietary composition on fecal bile acid profiles in healthy subjects.
    Nagengast FM; van der Werf SD; Lamers HL; Hectors MP; Buys WC; van Tongeren JM
    Dig Dis Sci; 1988 Jun; 33(6):673-8. PubMed ID: 3371139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoprevention of colorectal cancer with ursodeoxycholic acid: cons.
    Carey EJ; Lindor KD
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S61-4. PubMed ID: 23141896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.